APA

Nakama T., Yoshida S., Ishikawa K., Kobayashi Y., Zhou Y., Nakao S., Sassa Y., Oshima Y., Takao K., Shimahara A., Yoshikawa K., Hamasaki T., Ohgi T., Hayashi H., Matsuda A., Kudo A., Nozaki M., Ogura Y., Kuroda M. & Ishibashi T. (20150930). Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. : Gene therapy.

Chicago

Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M and Ishibashi T. 20150930. Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. : Gene therapy.

Harvard

Nakama T., Yoshida S., Ishikawa K., Kobayashi Y., Zhou Y., Nakao S., Sassa Y., Oshima Y., Takao K., Shimahara A., Yoshikawa K., Hamasaki T., Ohgi T., Hayashi H., Matsuda A., Kudo A., Nozaki M., Ogura Y., Kuroda M. and Ishibashi T. (20150930). Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. : Gene therapy.

MLA

Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M and Ishibashi T. Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. : Gene therapy. 20150930.